FibroBiologics (NASDAQ:FBLG) Earns “Buy” Rating from HC Wainwright
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports. They presently have a $12.00 price objective on the stock. A number of other research analysts have also issued reports on the stock. Rodman & Renshaw […]
FibroBiologics (NASDAQ:FBLG – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued to investors on Thursday,Benzinga reports. They presently have a $12.00 price objective on the stock. A number of other research analysts have also issued reports on the stock. Rodman & Renshaw […]
